Literature DB >> 28283381

A Comprehensive Review of the Quality and Feasibility of Dementia Assessment Measures: The Dementia Outcomes Measurement Suite.

Adam Bentvelzen1, Liesbeth Aerts1, Katrin Seeher1, Jacqueline Wesson2, Henry Brodaty3.   

Abstract

The diagnosis of dementia and the management of its associated symptoms are aided by high-quality assessment tools. However, there is disagreement on the optimal tools among abundant alternatives and lack of consistent quality standards across the different domains of dementia-related change (ie, cognition, severity, function, behavioral and psychological symptoms, delirium, quality of life). Standardization is difficult because the relevance of a measurement tool for health professionals may depend on the clinical setting and on the dementia type and severity. To address this need, we conducted a comprehensive and clinically relevant evidence-based review of dementia-related tools and present a set of recommended tools, the Dementia Outcomes Measurement Suite. The review revealed that considerable development has occurred in terms of assessment of persons with mild cognitive impairment, executive dysfunction, cognitively mediated functional change, and apathy. More research is needed to develop and validate tools to assess health-related quality of life and specific symptoms of dementia including anxiety, wandering, and repetitive vocalizations. This extensive overview of the quality of different measures may serve as a guide for health professionals clinically and for researchers developing new or improved dementia assessment tools.
Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; assessment; clinical; measure; outcome; screen

Mesh:

Year:  2017        PMID: 28283381     DOI: 10.1016/j.jamda.2017.01.006

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  7 in total

1.  Variation and Interactional Non-Standardization in Neuropsychological Tests: The Case of the Addenbrooke's Cognitive Examination.

Authors:  Danielle Jones; Ray Wilkinson; Clare Jackson; Paul Drew
Journal:  Qual Health Res       Date:  2019-09-25

2.  Health-related quality-of-life assessment in dementia: Evidence of cross-cultural validity in Latin America.

Authors:  Kia-Chong Chua; Jan R Böhnke; Martin Prince; Sube Banerjee
Journal:  Psychol Assess       Date:  2019-07-08

3.  The DemWG study: reducing the risk of hospitalisation through a complex intervention for people with dementia and mild cognitive impairment (MCI) in German shared-housing arrangements: study protocol of a prospective, mixed-methods, multicentre, cluster-randomised controlled trial.

Authors:  André Kratzer; Jennifer Scheel; Karin Wolf-Ostermann; Annika Schmidt; Katrin Ratz; Carolin Donath; Elmar Graessel
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

Review 4.  Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives.

Authors:  Matteo Cotta Ramusino; Giulia Perini; Daniele Altomare; Paola Barbarino; Wendy Weidner; Gabriella Salvini Porro; Frederik Barkhof; Gil D Rabinovici; Wiesje M van der Flier; Giovanni B Frisoni; Valentina Garibotto; Stefan Teipel; Marina Boccardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-17       Impact factor: 9.236

5.  Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data.

Authors:  Francesca Conca; Valentina Esposito; Francesco Rundo; Davide Quaranta; Cristina Muscio; Rosa Manenti; Giulia Caruso; Ugo Lucca; Alessia Antonella Galbussera; Sonia Di Tella; Francesca Baglio; Federica L'Abbate; Elisa Canu; Valentina Catania; Massimo Filippi; Giulia Mattavelli; Barbara Poletti; Vincenzo Silani; Raffaele Lodi; Maddalena De Matteis; Michelangelo Stanzani Maserati; Andrea Arighi; Emanuela Rotondo; Antonio Tanzilli; Andrea Pace; Federica Garramone; Carlo Cavaliere; Matteo Pardini; Cristiano Rizzetto; Sandro Sorbi; Roberta Perri; Pietro Tiraboschi; Nicola Canessa; Maria Cotelli; Raffaele Ferri; Sandra Weintraub; Camillo Marra; Fabrizio Tagliavini; Eleonora Catricalà; Stefano Francesco Cappa
Journal:  Alzheimers Res Ther       Date:  2022-08-19       Impact factor: 8.823

Review 6.  Categorizing Health Outcomes and Efficacy of mHealth Apps for Persons With Cognitive Impairment: A Systematic Review.

Authors:  Daniel R Bateman; Bhavana Srinivas; Thomas W Emmett; Titus K Schleyer; Richard J Holden; Hugh C Hendrie; Christopher M Callahan
Journal:  J Med Internet Res       Date:  2017-08-30       Impact factor: 5.428

7.  Quality of life in small-scaled homelike nursing homes: an 8-month controlled trial.

Authors:  Jeroen S Kok; Marjan M A Nielen; Erik J A Scherder
Journal:  Health Qual Life Outcomes       Date:  2018-02-27       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.